Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer
Egyptian journal of Immunology · 01.10.2024 · 31 (4) · 27-35
DOI: 10.55133/eji.310403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian journal of Immunology, online erschienen am 01.10.2024. Verfasst von Mina Abd El Malak. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Ulcerative colitis (UC), a chronic idiopathic inflammatory disease, is caused by abnormal immune response to intestinal microflora. Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality. The gold standard to establish diagnosis and assess disease activity remains endoscopy and histopathology. Non-invasive biomarkers are required for timely diagnosis of CRC and to assess disease activity as endoscopic assessment is not accepted by most patients. Enhanced trefoil factor 3 (TFF3) expression is seen following gastrointestinal tract injury. In the current study, the significance of serum TFF3 as a potential diagnostic biomarker of disease activity in naїve UC patients, and its diagnostic accuracy in CRC patients were investigated. We collected serum and fecal samples from 20 cases with active UC, 20 CRC patients, and 20 normal controls. TFF3 levels were higher in patients with active UC than in controls (p
Zitieren
APA
Malak, M. A. E. (2024). Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer. Egyptian journal of Immunology, 31(4), 27-35. https://doi.org/10.55133/eji.310403
Vancouver
Malak MAE. Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer. Egyptian journal of Immunology. 2024;31(4):27-35. doi:10.55133/eji.310403
BibTeX
@article{Malak2024,
author = {Malak, Mina Abd El},
title = {Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer},
journal = {Egyptian journal of Immunology},
year = {2024},
volume = {31},
number = {4},
pages = {27--35},
doi = {10.55133/eji.310403}
}
EUVIMED